NEUROSOMIX
Live / Applied — Response to non-final action entered (as of 10 Sept 2026)
What this means for you
Not registered yet, but its 17 Jun 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79430633
- Mark type
- Stylized text
- Filed
- 17 Jun 2025
- Attorney of record
- Victoria A Guzman, Esq.
Goods and services
- Class 001 — Chemicals: Chemical preparations for analyses in laboratories, except for medical or veterinary use; chemical reagents, except for medical or veterinary purposes; diagnostic preparations and diagnostic reagents, except for medical or veterinary use; chemical diagnostic preparations for scientific purposes; diagnostic scanning agents for in vivo scientific use; diagnostic preparations for clinical diagnostic use, except for medical or veterinary use; diagnostic kits comprising sample receptors, synthetic antibody-like bioreceptors for the detection of biomarkers related oncology and immunoassay reagents, antibodies and assay controls for scientific use for analyzing selected bacteria, except for medical or veterinary use; diagnostic test materials, except for medical use, namely, diagnostic preparations for in vitro testing for scientific use; chemical preparations for use in immunoassay testing, except for medical or veterinary use; immunoassay reagents, except for medical or veterinary use.
- Class 005 — Pharmaceuticals: Skin cleansing preparations for medical use; biological preparations for use in cell cultures for medical purposes; chemical preparations for medical use, namely, for the treatment and detection of cancer; chemico-pharmaceutical preparations for the treatment and detection of cancer; diagnostic preparations for medical use; chemical reagents for medical or veterinary use; diagnostic reagents for medical use; reagents for clinical diagnosis for medical use; reagents for clinical analysis for medical use; reagents with biomarkers for medical diagnostics; immunoassay reagents for medical use; diagnostic test materials for medical use, namely, diagnostic test reagents for medical use
- Class 010 — Medical apparatus: Medical apparatus and instruments, namely, in vitro diagnostic devices for the detection, assessment, evolution and response to treatment of diseases based on the analysis of biomarkers in extracellular vesicles derived from neurons; diagnostic apparatus for medical use, namely, medical diagnostic apparatus for testing in vitro diagnostic devices for the detection, assessment, evolution, and tracking of the response to treatment of cancerous diseases based on analysis of biomarkers in extracellular vesicles derived from cancer; detector apparatus for medical use in diagnostics, namely, medical diagnostic apparatus for testing in vitro diagnostic devices for the detection, assessment, evolution, and tracking of the response to treatment of cancerous diseases based on analysis of biomarkers in extracellular vesicles derived from cancer; diagnostic testing apparatus for medical purposes for detecting cancer; medical equipment for diagnosis, examination, and monitoring in the nature of respiratory equipment and monitors for the same; tools for medical diagnostics, namely, medical devices and surgical instruments for use in diagnosis and surgery of the gastrointestinal tract; medical diagnostic instruments for the analysis of bodily fluids; testing instruments for medical diagnostic use in the nature of ultrasonic medical diagnostic apparatus; medical diagnostic instruments for use in immunoassay procedures, in the nature of immunochemical medical diagnostic apparatus for detecting and measuring antibody levels; immunological analyzers in the nature of immunochemical testing apparatus for medical use
Owner
Prosecution history
- 10 Sept 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Sept 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Sept 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 26 Mar 2026 — REFUSAL PROCESSED BY IB
- 11 Mar 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 11 Mar 2026 — REFUSAL PROCESSED BY MPU
- 07 Feb 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 06 Feb 2026 — NON-FINAL ACTION WRITTEN
- 31 Jan 2026 — ASSIGNED TO EXAMINER
- 30 Jan 2026 — APPLICATION FILING RECEIPT MAILED
- 30 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 Sept 2025 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
- 21 Aug 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB